FesariusTherapeutics inks manufacturing & supply agreement with Regenity Biosciences for DermiSphere hDRT, the first hydrogel dermal regeneration template

Join Pharma | Login

	Editorial


	MAKE PIC/S DREAM A REALITY
	Wednesday, April 16, 2025
	The Indian pharmaceutical industry has long been supplying over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	FesariusTherapeutics inks manufacturing & supply agreement with Regenity Biosciences for DermiSphere hDRT, the first hydrogel dermal regeneration template
17:00 [IST]	INmune Bio to receive US patent for next-generation mesenchymal stromal cell product, CORDStrom
16:00 [IST]	Chime Biologics and Polpharma Biologics partner to advance biosimilar development
15:00 [IST]	Cullinan Therapeutics gets EMA approval to begin phase 1 trial of CLN-978, a bispecific CD19 T cell engager administered RA
14:00 [IST]	Autonomix Medical receives European patent for proprietary catheter-based technology
13:50 [IST]	Glenmark Pharma to introduce generic Adderall tablets in 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg strengths in May 2025

more news >>

TOP NEWS


08:00 [IST]	Panel asks DoP to expedite setting up of PMRUs in remaining States
08:00 [IST]	Bavarian State Govt to give fillip to Karnataka life science cos by infusing expertise in technology
08:00 [IST]	NABL rolls out amended accreditation criteria for QA testing of diagnostic radiology X-Ray equipment
08:00 [IST]	Pharmacists’ role is essential to reshape Indian healthcare delivery system: Kamal Mehrotra
08:00 [IST]	Physiotherapy bridges gap between medical interventions and holistic recovery: Dr. Sumandeep Kaur
08:00 [IST]	Health ministry restricts use of common cold medicine in children below four years

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Meribel Pharma Solutions launches network across Europe to elevate pharma services to new heights
17:00 [IST]	Scipher Medicine inks partnership with Kythera Labs to unlock new insights into autoimmune disease-specific treatment
16:15 [IST]	Abbott with IQVIA highlights reality of vertigo in India
16:00 [IST]	LUMA Vision receives US FDA clearance for Verafeye 2D/4D cardiac visualization platform
15:45 [IST]	Sterling Accuris strengthens presence in diagnostics through acquisition of Gujarat Pathology Laboratory and Diagnostic Centre
12:15 [IST]	Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

US tariff exemption to bolster Indian pharma global presence with supply of high quality medicines Insulin Aspart 100 Iu/ml, Pack Of 3 Ml Brivaracetam 100mg Tab Mebeverine 135mg Tab Levofloxacin 500mg 100ml Infusion

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers